Management of Ruptured Anterior Communicating Artery (ACoA) Aneurysms – Evidence‑Based Recommendations

Initial Evaluation and Diagnosis

• Digital subtraction angiography with 3‑D rotational acquisition is the gold‑standard imaging modality for detecting ruptured ACoA aneurysms and for planning whether endovascular coiling or microsurgical clipping is feasible (provides highest anatomical detail) 1, 2.
• If computed tomography angiography (CTA) raises strong suspicion but remains inconclusive, patients should proceed directly to DSA rather than additional non‑invasive studies to avoid diagnostic delay 3.
• CTA demonstrates a sensitivity of 77‑97 % and specificity of 87‑100 % for aneurysms as small as 2–3 mm; when arterial‑phase imaging supplies adequate detail, CTA may be sufficient for treatment planning 4, 5.
• Validated clinical grading scales (Hunt‑Hess or World Federation of Neurological Societies) must be applied immediately on presentation to stratify severity and predict outcome 3.

Blood‑Pressure Management (Pre‑Securing)

• Systolic blood pressure should be kept < 160 mmHg using short‑acting, titratable agents, while avoiding severe hypotension and large BP variability; this balances the risk of re‑bleeding against the need for adequate cerebral perfusion pressure 3, 2.

Treatment Selection for Good‑Grade Ruptured ACoA Aneurysms

• Primary endovascular coiling is recommended over microsurgical clipping for good‑grade ruptured ACoA aneurysms that are equally suitable for either technique (Class I, Level A) because it improves 1‑year functional outcomes 3, 1.
• Both coiling and clipping remain reasonable options for achieving favorable long‑term outcomes when patient‑specific factors do not clearly favor one modality 1.

Factors Favoring Microsurgical Clipping

• Patients younger than 40 years may benefit from clipping for greater durability and long‑term outcome 1.
• When a large intraparenchymal hematoma (> 50 mL) is present with depressed consciousness, emergency clot evacuation combined with clipping is indicated to reduce mortality 3, 1.

Factors Favoring Endovascular Coiling

• Patients older than 70 years may preferentially receive coiling, as superiority of clipping has not been established in this age group 1.
• Poor‑grade presentations (WFNS IV/V) are better managed with coiling 2.

Device‑Specific Considerations

• Stents or flow‑diverters should not be used for ruptured saccular ACoA aneurysms that are amenable to primary coiling or clipping (Class III – Harm) because of higher complication rates and the need for antiplatelet therapy 3, 1.
• For wide‑neck aneurysms that cannot be treated with clipping or primary coiling, stent‑assisted coiling or flow‑diverter placement is reasonable 1.

Transfer and Systems of Care

• Patients should be transferred promptly to high‑volume centers that provide neurocritical‑care services and have both neuroendovascular and cerebrovascular surgeons on site 3.
• Management must occur in a dedicated neurocritical‑care unit staffed by a multidisciplinary team 3.
• Evaluation by specialists with expertise in both endovascular and surgical techniques is essential to weigh relative risks and benefits 3, 1.

Medical Management

• Routine antifibrinolytic therapy is not recommended 3.
• Routine statin therapy for outcome improvement is not recommended 3.
• Routine intravenous magnesium for outcome improvement is not recommended 3.
• Emergency reversal of any anticoagulation should be performed immediately in patients presenting with acute subarachnoid hemorrhage 3.
• Acute symptomatic hydrocephalus requires urgent cerebrospinal‑fluid diversion using a bundled protocol 3.
• Chronic symptomatic hydrocephalus requires permanent cerebrospinal‑fluid diversion 3.
• After aneurysm securing, pharmacologic venous‑thromboembolism prophylaxis should be initiated 3.
• Phenytoin should be avoided for seizure prophylaxis because it is associated with excess morbidity and mortality 3.
• Prophylactic hypervolemia or hemodynamic augmentation should not be performed (Class III – Harm) 3, 2.

Follow‑Up and Surveillance

• Immediate post‑treatment cerebrovascular imaging is mandatory after any aneurysm repair to detect residual filling or recurrence that may require further intervention 2.
• Delayed follow‑up vascular imaging (timing and modality individualized) is indicated; retreatment should be strongly considered when a clinically significant residual aneurysm is identified 2.
• When complete obliteration cannot be achieved acutely, a strategy of partial occlusion to secure the rupture site followed by delayed retreatment after functional recovery is reasonable 1.

Critical Pitfalls to Avoid

• Do not delay aneurysm securing; early treatment reduces re‑bleeding risk and facilitates management of delayed cerebral ischemia 1.
• Do not use routine antifibrinolytic agents 3.
• Do not induce hypervolemia 3.
• Do not employ stents or flow diverters for standard saccular aneurysms amenable to primary coiling or clipping 3, 1.
• Transcranial Doppler monitoring for vasospasm is reasonable, but prophylactic balloon angioplasty before vasospasm development is not recommended 2.

Manejo de la Hemorragia Subaracnoidea Aneurismática

Diagnóstico y Evaluación Inicial

• La hemorragia subaracnoidea aneurismática (HSA) es una emergencia médica frecuentemente mal diagnosticada y debe mantenerse un alto nivel de sospecha en pacientes con cefalea severa de inicio súbito 6, 7.
• La evaluación diagnóstica inicial debe incluir una TC cerebral sin contraste, y si es no diagnóstica, debe seguirse de una punción lumbar 6, 7.
• La gravedad clínica inicial de la HSA debe determinarse rápidamente mediante escalas validadas, como la escala de Hunt y Hess o la de la Federación Mundial de Sociedades Neurológicas, ya que es el indicador más útil del resultado 6, 7.
• La angiografía por sustracción digital (ASD) con reconstrucción 3D está indicada para la detección del aneurisma en pacientes con HSA y para planificar el tratamiento 6, 7, 8.

Manejo del Aneurisma

• El tratamiento del aneurisma roto debe realizarse lo antes posible para reducir el riesgo de resangrado 6, 7, 8.
• Para pacientes con HSA de buen grado clínico con aneurismas rotos de circulación anterior, se recomienda el coiling para mejorar el resultado funcional a 1 año 8, 9, 10.
• Para pacientes con HSA por aneurismas rotos de circulación posterior que son susceptibles de coiling, éste está indicado con preferencia al clipaje 8, 9, 10.

Manejo Médico

• El nimodipino oral debe administrarse a todos los pacientes con HSA a dosis de 60 mg cada 4 horas durante 21 días consecutivos, comenzando dentro de las 96 horas del inicio de la HSA 6, 7.
• La presión arterial debe controlarse con un agente titulable para equilibrar el riesgo de ictus, resangrado relacionado con hipertensión y mantenimiento de la presión de perfusión cerebral 6, 7, 11.
• Se recomienda reducción gradual de la PA cuando los pacientes están severamente hipertensos, evitando estrictamente la hipotensión 8, 11.

Manejo de Complicaciones

• La hidrocefalia sintomática aguda asociada a HSA debe manejarse mediante derivación del líquido cefalorraquídeo 6, 7, 8.
• La hidrocefalia crónica sintomática debe tratarse con derivación permanente del líquido cefalorraquídeo 7, 12.
• No se recomienda el uso rutinario de terapia antifibrinolítica 8, 13.
• No se recomienda la terapia rutinaria con estatinas para mejorar los resultados 13, 14.

Consideraciones para el Traslado y Atención

• Los hospitales de bajo volumen deben considerar la transferencia temprana de pacientes con HSA a centros de alto volumen con cirujanos cerebrovasculares experimentados y servicios de neurointensivos multidisciplinarios 6, 7, 8.
• La atención debe proporcionarse en una unidad de cuidados neurointensivos por un equipo multidisciplinario 13, 14.

Complicaciones Médicas

• Se debe realizar una identificación temprana y tratamiento dirigido de la trombocitopenia inducida por heparina y la trombosis venosa profunda 6, 7.

Seguimiento

• Después de cualquier reparación de aneurisma, se recomienda generalmente una imagen cerebrovascular inmediata para identificar remanentes o recurrencia del aneurisma que puedan requerir tratamiento 6, 7, 12.
• En ausencia de una contraindicación convincente, los pacientes que se someten a coiling o clipaje de un aneurisma roto deben tener seguimiento vascular diferido, y debe considerarse seriamente el retratamiento si hay un remanente clínicamente significativo 6, 7, 12.